Sign In
Buy ELVN
Enliven Therapeutics Stock Insider Power
Based on the 100 latest insides trades, we have calculated the insider power to be negative at -85.25. In total, the insiders bought 2.07M and sold 1.63M ELVN shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.
Insider Power
|
-85.25 |
| ● Buy | 2.07M shares |
| ● Sell | 1.63M shares |
|
44% Buy Activity
Negligible or No Correlation
|
|
Historical Insider Trades
| Date | Type | Person | Role | Amount |
|---|---|---|---|---|
|
Jul 06, 2026 Sell |
Kunkel Lori Anne Director |
5 889 Value: $299.4K |
||
|
Jul 06, 2026 Sell |
Kunkel Lori Anne Director |
4 111 Value: $205.5K |
||
|
Jun 22, 2026 Sell |
Orbimed Advisors Llc 10 Percent Owner |
787 024 Value: $35.7M |
||
|
Jun 22, 2026 Sell |
Orbimed Advisors Llc 10 Percent Owner |
46 776 Value: $2.10M |
||
|
Jun 22, 2026 Sell |
Orbimed Advisors Llc 10 Percent Owner |
24 846 Value: $1.13M |
||
|
Jun 22, 2026 Sell |
Orbimed Advisors Llc 10 Percent Owner |
1 477 Value: $66.5K |
||
|
Jun 17, 2026 Sell |
Collins Helen Louise Chief Medical Officer |
1 133 Value: $50.7K |
||
|
Jun 17, 2026 Sell |
Collins Helen Louise Chief Medical Officer |
2 599 Value: $114.0K |
||
|
Jun 17, 2026 Sell |
Collins Helen Louise Chief Medical Officer |
1 268 Value: $54.3K |
||
|
Jun 17, 2026 Buy |
Collins Helen Louise Chief Medical Officer |
5 000 Value: $12.4K |
||
|
Jun 17, 2026 Sell |
Hohl Benjamin Chief Financial Officer |
3 401 Value: $149.2K |
||
|
Jun 17, 2026 Sell |
Hohl Benjamin Chief Financial Officer |
1 379 Value: $59.0K |
||
|
Jun 17, 2026 Buy |
Hohl Benjamin Chief Financial Officer |
6 018 Value: $14.9K |
||
|
Jun 17, 2026 Buy |
Hohl Benjamin Chief Financial Officer |
6 018 Value: $14.9K |
||
|
Jun 17, 2026 Sell |
Hohl Benjamin Chief Financial Officer |
1 238 Value: $55.4K |
||
|
Jun 17, 2026 Buy |
Collins Helen Louise Chief Medical Officer |
5 000 Value: $12.4K |
||
|
Jun 15, 2026 Sell |
Orbimed Advisors Llc 10 Percent Owner |
9 086 Value: $409.1K |
||
|
Jun 15, 2026 Sell |
Orbimed Advisors Llc 10 Percent Owner |
272 322 Value: $12.3M |
||
|
Jun 05, 2026 Sell |
Kunkel Lori Anne Director |
7 779 Value: $266.7K |
||
|
Jun 05, 2026 Sell |
Kunkel Lori Anne Director |
354 Value: $12.7K |
||
|
Jun 05, 2026 Sell |
Kunkel Lori Anne Director |
1 867 Value: $66.0K |
||
|
May 18, 2026 Sell |
Collins Helen Louise Chief Medical Officer |
1 302 Value: $52.4K |
||
|
May 18, 2026 Sell |
Collins Helen Louise Chief Medical Officer |
3 475 Value: $137.4K |
||
|
May 18, 2026 Buy |
Collins Helen Louise Chief Medical Officer |
5 000 Value: $12.4K |
||
|
May 18, 2026 Buy |
Collins Helen Louise Chief Medical Officer |
5 000 Value: $12.4K |
About Insider Power
Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.
It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.
While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.
* October 6th, 2025 - Tested on 5562 stocks
